LYRA — Lyra Therapeutics, Inc.
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1327273 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 7,000 | — | -6,911,000 | -6,951,000 | 36,108,000 | 15,893,000 | 46,825,000 |
| Sep 2025 | 25,000 | — | -6,258,000 | -5,984,000 | 43,709,000 | 22,055,000 | 48,037,000 |
| Jun 2025 | 183,000 | — | -8,428,000 | -7,437,000 | 52,573,000 | 29,784,000 | 50,951,000 |
| Mar 2025 | 183,000 | — | -7,956,000 | -8,547,000 | 56,316,000 | 31,735,000 | 52,444,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-28,859,000
Investing CF
$-98,000
Financing CF
$4,273,000
CapEx
$-147,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-24.46
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-433,709,000
Inventory
—
Receivables
—
ST Investments
$0
EBIT TTM
$-29,553,000
Pretax Income TTM
$-28,908,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$398,000
EBITDA
$-29,094,000
Free Cash Flow
$-17,529,624
Enterprise Value
$15,697,162
Total Cash
$15,893,000
Total Debt
$30,259,000
Shares Out
1,774,882
Trailing EPS
$-18.62
Book Value
$-6.04
ROE
-6595.0%
ROA
-36.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 398,000 | -29,553,000 | -28,919,000 | 36,108,000 | 46,825,000 | — | -28,859,000 |
| Dec 2024 | 1,534,000 | -60,733,000 | -93,435,000 | 66,346,000 | 54,752,000 | — | -70,011,000 |
| Dec 2023 | 1,558,000 | -65,528,000 | -62,680,000 | 142,600,000 | 53,180,000 | — | -63,304,000 |
| Dec 2022 | 1,363,000 | -54,990,000 | -55,278,000 | 109,968,000 | 29,214,000 | — | -43,385,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.99
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $154.64B | $436.64 | — |
| SYK | STRYKER CORP | $119.99B | $313.00 | — |
| MDT | Medtronic plc | $99.63B | $77.60 | — |
| BSX | BOSTON SCIENTIFIC CORP | $85.67B | $57.64 | — |
| MMM | 3M CO | $80.34B | $154.03 | — |
News headlines (Yahoo Finance, 1h cache)
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
2026-04-17 12:00 · Yahoo
Lyra Therapeutics suspends further development of LYR-210
2026-01-13 12:26 · Yahoo
Top Midday Decliners
2026-01-12 20:18 · Yahoo
Lyra Therapeutics Provides Corporate Update
2026-01-12 12:00 · Yahoo
Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-12 21:01 · Yahoo
Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates
2025-11-10 22:45 · Yahoo
Dentsply International (XRAY) Lags Q3 Earnings Estimates
2025-11-06 14:15 · Yahoo
Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates
2025-11-04 14:15 · Yahoo
Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study
2025-10-06 11:00 · Yahoo
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates
2025-08-12 21:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.